BioCatalyst

HDM1002 200 mg, HDM1002 400 mg — catalyst calendar

1 verified catalyst event(s) referencing HDM1002 200 mg, HDM1002 400 mg, each linked to its official source. Verified as of 2026-08-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-10
in 2mo
ESTIMATED
 READOUT
Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
Phase 3 · Type 2 Diabetes
 Hangzhou Zhongmei Huadong Pharmace HDM1002 200 mg, HDM1002 400 mg ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.